Productos farmacéuticos y dispositivos médicos
Featured news
AIM successfully launches its Calculator for Fair Medicines Prices in Europe
The International Association of Mutual Benefit Societies (AIM) has launched today its calculator for fair medicines prices in Europe (German version here). The calculator transposes AIM's fair pricin......
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union
AIM, the International Association of Mutual Benefit Societies, has articulated a set of recommendations to rebalance pharmaceutical markets in Europe. AIM calls for the European Pharmaceutical Str......
Other news
Payer involvement is important for a successful EU HTA framework!
The International Association of Mutual Benefit Societies (AIM) welcom...
AIM successfully launches its Calculator for Fair Medicines Prices in Europe
The International Association of Mutual Benefit Societies (AIM) has la...
Joint Statement – Transparency is needed to reap the full benefits of the EU’s investment in its Vaccines Strategy
Ahead of Friday 18 September's webinar the EU Vaccine Strategy, a numb...
AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union
AIM, the International Association of Mutual Benefit Societies, has ar...
EU Collaboration on Vaccination
The current outbreak of COVID-19, its crippling effects on European ec...
European patients need fair medicines prices
The press regularly announces the discovery of a new drug or the purch...
Medical Devices: Time to implement Regulations and increase Transparency
AIM, together with the European Association of Hospital Pharmacists (E...
AIM director’s interview on HTA
AIM’s perspectives on Health Technology Assessments – An EU-wide a...
AIM publishes position on TFAs
AIM answered the open public consultation on the initiative to limit i...